AACR: Drug Duo Linked to Major Drop in Adenoma Recurrence
http://... Meyskens, M.D., of the University of California IrvineSAN DIEGO, April 15 -- The risk of colonic adenoma recurrence fell by as much as 95% over three years in high-risk patients treated with a combination of difluoromethylornithine (DFMO) and sulindac, according to data reported here.
![Alicia Keys&Jack White - Another Way To Die [Official Video]](http://i2.ytimg.com/vi/hM5UJvnbbuY/default.jpg)
